{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T20:57:57Z","timestamp":1721509077778},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,15]]},"DOI":"10.1093\/infdis\/jiu180","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T03:03:13Z","timestamp":1395370993000},"page":"890-898","source":"Crossref","is-referenced-by-count":20,"title":["Maraviroc Reduces the Regulatory T-Cell Frequency in Antiretroviral-Naive HIV-Infected Subjects"],"prefix":"10.1093","volume":"210","author":[{"given":"Mar\u00eda Mar","family":"Pozo-Balado","sequence":"first","affiliation":[{"name":"Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Roc\u00edo University Hospital\/CSIC\/University of Seville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mart\u00ednez-Bonet","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunobiology, Hospital General Universitario Gregorio Mara\u00f1on, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Rosado","sequence":"additional","affiliation":[{"name":"Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Roc\u00edo University Hospital\/CSIC\/University of Seville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezequiel","family":"Ruiz-Mateos","sequence":"additional","affiliation":[{"name":"Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Roc\u00edo University Hospital\/CSIC\/University of Seville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"M\u00e9ndez-Lagares","sequence":"additional","affiliation":[{"name":"Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Roc\u00edo University Hospital\/CSIC\/University of Seville"},{"name":"Department of Medical Microbiology and Immunology, University of California, Davis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Mar","family":"Rodr\u00edguez-M\u00e9ndez","sequence":"additional","affiliation":[{"name":"Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Roc\u00edo University Hospital\/CSIC\/University of Seville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Vidal","sequence":"additional","affiliation":[{"name":"Infectious Diseases and HIV\/AIDS Unit, Department of Internal Medicine, Hospital Universitari de Tarragona Joan XXIII, Universitat Rovira i Virgili, IISPV, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Angeles","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunobiology, Hospital General Universitario Gregorio Mara\u00f1on, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda Mar\u00eda","family":"Pacheco","sequence":"additional","affiliation":[{"name":"Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Roc\u00edo University Hospital\/CSIC\/University of Seville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Leal","sequence":"additional","affiliation":[{"name":"Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Roc\u00edo University Hospital\/CSIC\/University of Seville"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,3,20]]},"reference":[{"key":"key\n\t\t\t\t20180328162954_JIU180C1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4049\/jimmunol.182.1.171","article-title":"CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation","volume":"182","author":"Camargo","year":"2009","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180328162954_JIU180C2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.296.7.815","article-title":"Biology of CCR5 and its role in HIV infection and treatment","volume":"296","author":"Lederman","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328162954_JIU180C3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2249.2011.04409.x","article-title":"In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells","volume":"166","author":"Rossi","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20180328162954_JIU180C4","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm1319","article-title":"Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1","volume":"11","author":"F\u00e4tkenheuer","year":"2005","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180328162954_JIU180C5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-med-052010-145454","article-title":"CCR5 antagonism in HIV infection: current concepts and future opportunities","volume":"63","author":"Wilkin","year":"2012","journal-title":"Annu Rev Med"},{"key":"key\n\t\t\t\t20180328162954_JIU180C6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/QAI.0b013e3181c5c83b","article-title":"CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2","volume":"54","author":"Asmuth","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328162954_JIU180C7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1086\/598965","article-title":"A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1; A4001029 Study Group","volume":"199","author":"Saag","year":"2009","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328162954_JIU180C8","doi-asserted-by":"crossref","first-page":"e13188","DOI":"10.1371\/journal.pone.0013188","article-title":"Effects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patients","volume":"5","author":"Funderburg","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328162954_JIU180C9","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1128\/AAC.01406-12","article-title":"Effect of maraviroc on HIV disease progression-related biomarkers","volume":"56","author":"Romero-S\u00e1nchez","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328162954_JIU180C10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/infdis\/jis376","article-title":"A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4+ T-cell recovery despite sustained virologic suppression: ACTG A5256","volume":"206","author":"Wilkin","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328162954_JIU180C11","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2119\/molmed.2012.00206","article-title":"CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infection","volume":"18","author":"Westrop","year":"2012","journal-title":"Mol Med"},{"key":"key\n\t\t\t\t20180328162954_JIU180C12","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMra055446","article-title":"Regulation of immune responses by T-cells","volume":"354","author":"Jiang","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328162954_JIU180C13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2012-07-409755","article-title":"The split personality of regulatory T cells in HIV infection","volume":"121","author":"Chevalier","year":"2013","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328162954_JIU180C14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1086\/653707","article-title":"Increased regulatory T-cell counts in HIV-infected nonresponders to hepatitis B virus vaccine","volume":"202","author":"del Pozo-Balado Mdel","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328162954_JIU180C15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/eji.200838667","article-title":"High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts","volume":"39","author":"Bi","year":"2009","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t20180328162954_JIU180C16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/infdis\/jiq073","article-title":"Normalization of FoxP3(+) regulatory T-cells in response to effective antiretroviral therapy","volume":"203","author":"Montes","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328162954_JIU180C17","doi-asserted-by":"crossref","first-page":"e37966","DOI":"10.1371\/journal.pone.0037966","article-title":"Longitudinal changes of peripheral blood DC subsets and regulatory T-cells in Chinese chronic HIV-1-infected patients during antiretroviral therapy","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328162954_JIU180C18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2249.2008.03803.x","article-title":"Increased levels of regulatory T-cells (Treg) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Treg","volume":"155","author":"Kolte","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20180328162954_JIU180C19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2249.2008.03725.x","article-title":"Regulatory T-cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy","volume":"154","author":"Gaardbo","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20180328162954_JIU180C20","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/QAD.0b013e32825eab8b","article-title":"Proportions of circulating T-cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy","volume":"21","author":"Lim","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328162954_JIU180C21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/649840","article-title":"CD4(+)CD25(+\/hi)CD127(lo) phenotype does not accurately identify regulatory T-cells in all populations of HIV-infected persons","volume":"201","author":"Del Pozo-Balado Mdel","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328162954_JIU180C22","doi-asserted-by":"crossref","first-page":"e52580","DOI":"10.1371\/journal.pone.0052580","article-title":"Analysis of suppressor and non-suppressor FOXP3+ T cells in HIV-1-infected patients","volume":"7","author":"Arruvito","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328162954_JIU180C23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/jac\/dkp293","article-title":"Correlation between the Trofile test and virological response to a short-term maraviroc exposure in HIV-infected patients","volume":"64","author":"Genebat","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328162954_JIU180C24","first-page":"409","article-title":"CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literature","volume":"12","author":"Emmelkamp","year":"2007","journal-title":"Eur J Med Res"},{"key":"key\n\t\t\t\t20180328162954_JIU180C25","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0149-2918(08)80048-3","article-title":"Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection","volume":"30","author":"Lieberman-Blum","year":"2008","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20180328162954_JIU180C26","doi-asserted-by":"crossref","first-page":"12925","DOI":"10.1128\/JVI.01352-09","article-title":"Human regulatory T-cells are targets for human immunodeficiency virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain","volume":"83","author":"Moreno-Fernandez","year":"2009","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180328162954_JIU180C27","doi-asserted-by":"crossref","first-page":"996","DOI":"10.4049\/jimmunol.166.2.996","article-title":"Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity","volume":"166","author":"Sebastiani","year":"2001","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180328162954_JIU180C28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1615\/CritRevImmunol.v30.i5.30","article-title":"Regulatory T-cell trafficking: from thymic development to tumor-induced immune suppression","volume":"30","author":"Mailloux","year":"2010","journal-title":"Crit Rev Immunol"},{"key":"key\n\t\t\t\t20180328162954_JIU180C29","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1158\/0008-5472.CAN-11-3917","article-title":"CCR5 antagonist blocks metastasis of basal breast cancer cells","volume":"72","author":"Velasco-Vel\u00e1zquez","year":"2012","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180328162954_JIU180C30","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1158\/0008-5472.CAN-11-1156","article-title":"Targeting regulatory T-cells in cancer","volume":"71","author":"Byrne","year":"2011","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180328162954_JIU180C31","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/0008-5472.CAN-11-2493","article-title":"Tumor-derived chemokine CCL5 enhances TGF-\u03b2-mediated killing of CD8(+) T-cells in colon cancer by T-regulatory cells","volume":"72","author":"Chang","year":"2012","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180328162954_JIU180C32","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.4049\/jimmunol.1201018","article-title":"Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T-cells favoring tumor growth","volume":"189","author":"Schlecker","year":"2012","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180328162954_JIU180C33","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.182.3.1746","article-title":"Disruption of CCR5-dependent homing of regulatory T-cells inhibits tumor growth in a murine model of pancreatic cancer","volume":"182","author":"Tan","year":"2009","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180328162954_JIU180C34","doi-asserted-by":"crossref","first-page":"e23660","DOI":"10.4161\/onci.23660","article-title":"The CCL5\/CCR5 axis promotes metastasis in basal breast cancer","volume":"2","author":"Velasco-Vel\u00e1zquez","year":"2013","journal-title":"Oncoimmunology"},{"key":"key\n\t\t\t\t20180328162954_JIU180C35","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.4049\/jimmunol.1000032","article-title":"ccr5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T-cells in fungal infection","volume":"184","author":"Kroetz","year":"2010","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180328162954_JIU180C36","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1084\/jem.20060956","article-title":"CCR5-dependent homing of naturally occurring CD4+ regulatory T-cells to sites of Leishmania major infection favors pathogen persistence","volume":"203","author":"Yurchenko","year":"2006","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180328162954_JIU180C37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1201248","article-title":"Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease","volume":"367","author":"Reshef","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328162954_JIU180C38","doi-asserted-by":"crossref","first-page":"e11659","DOI":"10.1371\/journal.pone.0011659","article-title":"Relationship between regulatory T-cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy; ANRS 116 SALTO study group","volume":"5","author":"Weiss","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328162954_JIU180C39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/QAI.0b013e31827b51b5","article-title":"Maraviroc once-daily nucleoside analog-sparing regimen in treatment-naive patients: randomized, open-label pilot study","volume":"62","author":"Mills","year":"2013","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/210\/6\/890\/18070240\/jiu180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T05:15:08Z","timestamp":1522300508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/210\/6\/890\/2908532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,20]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,3,20]]},"published-print":{"date-parts":[[2014,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiu180","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,20]]}}}